Alpha Diagnostic Competitors and Similar CompaniesClear all

Alpha Diagnostic's competitors and similar companies include Genfit, Roche, Entegrion and Immunexpress.

	Alpha Diagnostic Alpha Diagnostic International (ADI) is a biotech company providing diagnostic reagents and test kits for animal and human diseases.	Genfit GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs.	Roche Roche Holding is a biotech company that provides in vitro diagnostics and supplies services.	Entegrion Entegrion is a life sciences company providing solutions for clinical diagnosis and management of hemostasis.	Immunexpress Immunexpress is a company creating molecular diagnostics for sepsis.
Founding Date	Founding Date 1993	Founding Date 1999	Founding Date 1896	Founding Date 2002	Founding Date 2006
Type	Type Private	Type Public	Type Public	Type Private	Type Private
Tags	Tags Healthcare biotech distribution drug development life sciences medical diagnostics medtech pharma	Tags Healthcare biotech drug development medical diagnostics pharma	Tags Healthcare biotech drug development medical diagnostics pharma	Tags Healthcare biotech life sciences medical diagnostics medtech pharma	Tags Healthcare drug development medical diagnostics medtech pharma
Locations	Locations San Antonio, US HQ San Antonio, US	Locations Loos, FR HQ Cambridge, US	Locations Basel, CH HQ Hydra, DZ Ricardo Rojas, AR North Ryde, AU Sydney, AU Wien, AT Dhaka, BD see more	Locations Durham, US HQ	Locations Seattle, US HQ
Employees	Employees N/A	Employees 180	Employees 103,249	Employees 128% decrease	Employees 14
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) €65.4m (FY, 2025)	Revenue (est.) CHF61.5b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods €302k (FY, 2025)	Cost of goods CHF13.1b (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit €70.8m (FY, 2025)	Gross profit CHF50.5b (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income N/A	Net income (€86m) (FY, 2025)	Net income CHF13.8b (FY, 2025)	Net income N/A	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 7.8b	Total funding raised $ 257.2k	Total funding raised $ 49m